Methyl 4-acetamido-5-chloro-2-(prop-2-yn-1-yloxy)benzoate
|
- $339 - $824
- Product name: Methyl 4-acetamido-5-chloro-2-(prop-2-yn-1-yloxy)benzoate
- CAS: 89481-87-8
- MF: C13H12ClNO4
- MW: 281.69
- EINECS:
- MDL Number:MFCD27665118
- Synonyms:Methyl 4-acetamido-5-chloro-2-(prop-2-yn-1-yloxy)benzoate;methyl 4-(acetylamino)-5-chloro-2-(2-propynyloxy)benzoate;Methyl5-chloro-4-acetamido-2-(prop-2-yn-1-yloxy)benzoate;Benzoic acid, 4-(acetylamino)-5-chloro-2-(2-propyn-1-yloxy)-, methyl ester
3 prices
Selected condition：
Brand
- Alichem
- Crysdot
- SynQuest Laboratories
Package
- 500mg
- 1g
- ManufacturerAlichem
- Product number89481878
- Product descriptionMethyl4-acetamido-5-chloro-2-(prop-2-yn-1-yloxy)benzoate
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12014301
- Product descriptionMethyl4-acetamido-5-chloro-2-(prop-2-yn-1-yloxy)benzoate 95+%
- Packaging1g
- Price$339
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4H58-5-1U
- Product descriptionMethyl 5-chloro-4-acetamido-2-(prop-2-yn-1-yloxy)benzoate
- Packaging500mg
- Price$824
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Alichem | 89481878 | Methyl4-acetamido-5-chloro-2-(prop-2-yn-1-yloxy)benzoate | 1g | $400 | 2021-12-16 | Buy |
| Crysdot | CD12014301 | Methyl4-acetamido-5-chloro-2-(prop-2-yn-1-yloxy)benzoate 95+% | 1g | $339 | 2021-12-16 | Buy |
| SynQuest Laboratories | 4H58-5-1U | Methyl 5-chloro-4-acetamido-2-(prop-2-yn-1-yloxy)benzoate | 500mg | $824 | 2021-12-16 | Buy |
Properties
Melting point :145.2 °C
Boiling point :480.6±45.0 °C(Predicted)
Density :1.321±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :13.08±0.70(Predicted)
Boiling point :480.6±45.0 °C(Predicted)
Density :1.321±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :13.08±0.70(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|